Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00790 (
PGA
)
2,475
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Poly(L-glutamic acid) (
PGA
) suppresses the polymerization of porcine brain microtubule proteins and induces the depolymerization in vitro in a concentration-dependent manner. The extent of inhibition increases with increasing molecular weight of the
PGA
tested. A 50% inhibition of the protein polymerization was observed at a
PGA
(molecular weight = 60,000) to microtubule protein ratio of 0.04 (w/w), and complete inhibition was obtained at a ratio of 0.07. Such an inhibition on the polymerization by
PGA
is greatly decreased when Mg2+ is present at a higher concentration. The addition of
PGA
raises the critical concentration of microtubule proteins necessary for assembly. During incubation with
PGA
, microtubule proteins retain the ability to assemble, i.e., substoichiometric amounts of taxol considerably relieve the inhibition of assembly by
PGA
.
PGA
interacts with microtubule-associated proteins (MAPs) preferentially, because the amount of MAPs binding to
PGA
-Sepharose 4B is much larger than that of tubulin. Tau proteins were observed only in adsorbed fractions, while
MAP-2
was present in both unbound and adsorbed fractions.
...
PMID:Inhibition of microtubule assembly by poly(L-glutamic acid) and the site of its action. 242 86